Long-acting GHRH analogue for sustained GH and IGF-1 elevation with weekly administration.

Product Overview

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue. The DAC modification enables albumin binding, extending activity over several days. Designed for once-weekly subcutaneous dosing and sustained GH/IGF-1 elevation. Used for GH-axis support, body composition and visceral adiposity protocols.

Composition

CJC-1295 with DAC 5mg

Strength & Volume

5mg | 2mL

Dosing System

200-click pen system

Per Click/Unit

0.025mg (25mcg) per click

Beginner Dose

20 clicks (500mcg)

Standard Dose

40 clicks (1,000mcg)

Max Dose

60 clicks (1,500mcg)

Frequency

Once weekly

Cycle Length & Off Period

8-12 weeks (GH-axis) | 12-24 weeks (extended) | Off Period: Varies

Key Benefits

Sustained GH elevation | IGF-1 support | Body composition | Visceral adiposity | Weekly dosing convenience

Expected Outcomes

Persistent elevation of GH and IGF-1 / potential improvements in lean tissue / exploratory data on visceral adiposity and metabolic parameters.

Warnings

Not suitable under 18 / during pregnancy / while breastfeeding. Always consult a healthcare professional. Disposable pen option is R50 extra.

Storage

Refrigerate at 2-8°C. Do not freeze.

Administration

Subcutaneous injection. Once weekly.

Kit Contents

1 x CJC-1295 DAC 5mg Cartridge + 1 x Replacement Needle

Related Products

CJC-1295 No DAC | Sermorelin | Ipamorelin | Tesamorelin | CTI